China's first domestic mpox vaccine approved for clinical trials

China delivered its first domestically developed mpox vaccine into clinical trials on Monday, Global Times reported.The vaccine, independently developed by the Shanghai Institute of Biological Products, a subsidy of the China National Pharmaceutical Group (Sinopharm), is based on a live, attenuated orthop...